None of the healthy individuals had B19V-specific IgM class antibodies, though 8% (16/200) of ME/CFS patients had IgM class antibodies (p = 0.0038). The gene discussed is CD40LG; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.